Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O'Brien, William Wierda, Hagop Kantarjian, Sijin Wen, Kim Anh Do, Deborah A. Thomas, Jorge Cortes, Susan Lerner, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

599 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds